HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Kim, S. J. Search for Related Content PubMed PubMed Citation Articles by Kim, S. J.

Drug-susceptibility testing in tuberculosis: methods and reliability of results

International Union Against Tuberculosis and Lung Disease, Paris, France

CORRESPONDENCE: S. J. Kim, International Union Against Tuberculosis and Lung Disease, 101–703 Unjeongmaul, Guseongup, Yonginsi, Kyeonggido 449-560, South Korea. Fax: 82 313044301. E-mail: SJKim@iuatld.org

Keywords: Drug resistance, drug-susceptibility testing, tuberculosis

Received: September 25, 2004
Accepted October 6, 2004

ABSTRACT

The demand for reliable drug-susceptibility testing (DST) increases with the expansion of antituberculosis drug-resistance surveillance, and with the need for an appropriate treatment of multidrug-resistant tuberculosis, whose incidence gradually increases in many parts of the world. However, the reliability of DST results obtained through widely used methods does not meet acceptable levels, except for DST to isoniazid and rifampicin.

In general, susceptibility results are highly predictable, while resistance results show low predictive values when the resistance prevalence is <10%. Poor reliability stems from a weak correlation with clinical response and a low reproducibility due to the poor standardisation of the complex and fragile test procedures. Therefore, in vitro criteria of resistance for susceptibility testing should be carefully determined with representative clinical samples of Mycobacterium tuberculosis isolated from patients never treated with any antituberculosis drug, and from patients having failed treatment with a regimen containing the tested drug; DST should then be carefully standardised to obtain reproducible results.

The critical concentration of some drugs is close to the minimal inhibitory concentration for wild susceptible strains and, thus, drug-susceptibility testing is prone to yield poorly reproducible results. These issues call for physicians' attention when using the results from drug-susceptibility testing for case management.

This article has been cited by other articles:

				B. Springer, R. C. Calligaris-Maibach, C. Ritter, and E. C. Bottger Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and Genotyping J. Clin. Microbiol., December 1, 2008; 46(12): 4064 - 4067. [Abstract] [Full Text] [PDF]

				G.-H. Bai, S.-J. Kim, C. L. Chang, and and Members of National and Regional Tuberculosis Proficiency Analysis of Drug Susceptibility Testing by National-Level Tuberculosis Reference Laboratories from 1995 to 2003 J. Clin. Microbiol., November 1, 2007; 45(11): 3626 - 3630. [Abstract] [Full Text] [PDF]

				G. Shiferaw, Y. Woldeamanuel, M. Gebeyehu, F. Girmachew, D. Demessie, and E. Lemma Evaluation of Microscopic Observation Drug Susceptibility Assay for Detection of Multidrug-Resistant Mycobacterium tuberculosis J. Clin. Microbiol., April 1, 2007; 45(4): 1093 - 1097. [Abstract] [Full Text] [PDF]

				C. Piersimoni, A. Olivieri, L. Benacchio, and C. Scarparo Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems J. Clin. Microbiol., January 1, 2006; 44(1): 20 - 28. [Full Text] [PDF]

				J. A. Caminero Management of multidrug-resistant tuberculosis and patients in retreatment Eur. Respir. J., May 1, 2005; 25(5): 928 - 936. [Abstract] [Full Text] [PDF]